This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Piper Jaffray Expands Biotechnology Research Platform with Addition Of Josh Schimmer, MD

Piper Jaffray (NYSE: PJC) is pleased to announce the hiring of Josh Schimmer, MD as a managing director and senior research analyst based in the firm’s New York office. Schimmer will be focused on small- and mid-cap biotechnology companies with specific emphasis in core therapeutic areas, commercialization and strategic partnerships.

Schimmer brings more than 10 years of experience to Piper Jaffray. He joined the firm from Lazard Capital Markets, and was previously at Cowen & Co., Leerink Swann, Deutsche Banc and Davidson Kempner. Schimmer holds a doctorate of medicine from the University of Toronto and a Master of Business Administration degree from Harvard Business School.

"Piper Jaffray has a strong team of healthcare professionals and we are excited to be adding another research specialist in biotechnology with Josh's hire," commented Steph Wissink, co-director of equity research for Piper Jaffray. "With increased emphasis on core growth areas of biotech, we see opportunities to serve the needs of our clients and build upon our market-leading healthcare platform."

Piper Jaffray has a total of 30 senior research analysts located in Minneapolis, New York, San Francisco and Chicago. The firm provides coverage on approximately 575 companies in the following key sectors: business & financial services; clean technology & industrial growth; consumer; healthcare; and technology, media & telecommunications.

About Piper JaffrayPiper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich. www.piperjaffray.com

Since 1895. Member NYSE and SIPC.© 2013 Piper Jaffray & Co.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs